The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-arm, open-label Phase 1b study of FP-1039/GSK3052230 with chemotherapy in malignant pleural mesothelioma (MPM).
 
Jose Manuel Trigo Perez
No Relationships to Disclose
 
Emilie Van Brummelen
No Relationships to Disclose
 
Evgeny Levchenko
No Relationships to Disclose
 
Manuel Domine
No Relationships to Disclose
 
Pilar Garrido Lopez
Consulting or Advisory Role - AstraZeneca; BJU International; Bristol-Myers Squibb; Novartis; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Novartis
Travel, Accommodations, Expenses - AstraZeneca; BJU International; Bristol-Myers Squibb
 
Hedy L. Kindler
Consulting or Advisory Role - Aduro Biotech; AstraZeneca; Bayer; Celgene; Genentech/Roche; Gilead Sciences; GlaxoSmithKline; MedImmune; Merck; Plexxikon; Verastem
Research Funding - AB Science; Aduro Biotech; Astellas Pharma; AstraZeneca; Bayer; Celgene; GlaxoSmithKline; Incyte; MedImmune; Merck; Verastem
Expert Testimony - Aduro Biotech
 
Daniel Morgensztern
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genentech; Heat Biologics
Speakers' Bureau - Boehringer Ingelheim; Genentech
Research Funding - AstraZeneca (Inst); Baxter (Inst); Celgene (Inst); Clovis Oncology (Inst); Heat Biologics (Inst); Incyte (Inst); Merck (Inst); Newlink Genetics (Inst); Stem CentRx (Inst)
 
Marjorie Glass Zauderer
Research Funding - GlaxoSmithKline (Inst); Lilly (Inst); MedImmune (Inst); Sella Life Sciences (Inst); Verastem (Inst)
 
Johan F. Vansteenkiste
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst)
Research Funding - AstraZeneca (Inst)
 
Santiago Viteri Ramirez
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology; Idea Pharma; Novartis; Theradex
Research Funding - Abbvie; ARIAD; Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; CytRx Corporation; Daiichi Sankyo; GlaxoSmithKline; Hanmi; Incyte; Merck KGaA; Novartis; Pfizer; Puma Biotechnology; Roche; VAXON Biotech
 
Katherine Baker Neblett
Employment - GlaxoSmithKline
Leadership - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Jeffrey Botbyl
Consulting or Advisory Role - GlaxoSmithKline
 
Eddie Jose
No Relationships to Disclose
 
Adina Zajac
No Relationships to Disclose
 
Ionel Mitrica
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Robert S. Sikorski
Employment - Five Prime Therapeutics
Leadership - Five Prime Therapeutics
Stock and Other Ownership Interests - Five Prime Therapeutics
Patents, Royalties, Other Intellectual Property - Five Prime Therapeutics
Travel, Accommodations, Expenses - Five Prime Therapeutics
 
Li Yan
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline; Johnson & Johnson; Merck
Patents, Royalties, Other Intellectual Property - Johnson & Johnson; Merck